Which assessment finding may indicate dehydration in a client receiving Cisplatin?

Dark urine is an important assessment finding that may indicate dehydration, especially in a client receiving Cisplatin. Cisplatin is a chemotherapeutic agent that can have nephrotoxic effects, particularly when the patient is not adequately hydrated. Dehydration leads to concentrated urine, which is often reflected in darker urine color due to higher levels of waste products. This color change serves as a visual cue that the kidneys may be working harder to conserve fluid and may also point to the risk of further kidney damage if hydration is not addressed.

In the context of Cisplatin, monitoring urine color becomes crucial as it can help assess kidney function and hydration status. Dark urine could signify that the kidneys are filtering concentrated waste, which can occur in the presence of dehydration. Therefore, identifying this symptom can prompt timely interventions to ensure the patient is adequately hydrated, potentially avoiding complications associated with renal function impairment.